SG10201804305SA - Stabilized ophthalmic galactomannan formulations - Google Patents
Stabilized ophthalmic galactomannan formulationsInfo
- Publication number
- SG10201804305SA SG10201804305SA SG10201804305SA SG10201804305SA SG10201804305SA SG 10201804305S A SG10201804305S A SG 10201804305SA SG 10201804305S A SG10201804305S A SG 10201804305SA SG 10201804305S A SG10201804305S A SG 10201804305SA SG 10201804305S A SG10201804305S A SG 10201804305SA
- Authority
- SG
- Singapore
- Prior art keywords
- formulations
- stabilized ophthalmic
- stabilized
- ophthalmic
- guar
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 6
- 239000000203 mixture Substances 0.000 title abstract 6
- 229920000926 Galactomannan Polymers 0.000 title abstract 3
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 title abstract 2
- -1 hydroxypropyl Chemical group 0.000 abstract 3
- 244000007835 Cyamopsis tetragonoloba Species 0.000 abstract 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 abstract 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 abstract 1
- 239000004327 boric acid Substances 0.000 abstract 1
- 150000002009 diols Chemical class 0.000 abstract 1
- 238000012377 drug delivery Methods 0.000 abstract 1
- 229910001629 magnesium chloride Inorganic materials 0.000 abstract 1
- 239000000600 sorbitol Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33151110P | 2010-05-05 | 2010-05-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201804305SA true SG10201804305SA (en) | 2018-06-28 |
Family
ID=44626461
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012081386A SG185422A1 (en) | 2010-05-05 | 2011-05-04 | Stabilized ophthalmic galactomannan formulations |
| SG10201804305SA SG10201804305SA (en) | 2010-05-05 | 2011-05-04 | Stabilized ophthalmic galactomannan formulations |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012081386A SG185422A1 (en) | 2010-05-05 | 2011-05-04 | Stabilized ophthalmic galactomannan formulations |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20110275593A1 (enExample) |
| EP (1) | EP2566447B1 (enExample) |
| JP (1) | JP5794744B2 (enExample) |
| KR (2) | KR20180001587A (enExample) |
| CN (2) | CN102939074A (enExample) |
| AR (1) | AR081015A1 (enExample) |
| AU (1) | AU2011248129B2 (enExample) |
| BR (1) | BR112012028308B1 (enExample) |
| CA (1) | CA2798069C (enExample) |
| ES (1) | ES2809304T3 (enExample) |
| MX (1) | MX2012012826A (enExample) |
| NZ (1) | NZ603345A (enExample) |
| SG (2) | SG185422A1 (enExample) |
| TW (1) | TWI606841B (enExample) |
| WO (1) | WO2011140203A2 (enExample) |
| ZA (1) | ZA201208199B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR071834A1 (es) * | 2008-04-26 | 2010-07-21 | Alcon Res Ltd | Sistema polimerico de lagrimas artificiales |
| TWI492769B (zh) * | 2009-09-23 | 2015-07-21 | Alcon Res Ltd | 可注射的水性眼用組成物及其使用之方法 |
| TW201336527A (zh) * | 2012-02-10 | 2013-09-16 | Alcon Res Ltd | 具增強的穩定性之水性藥學組成物 |
| UA113434C2 (uk) * | 2012-05-04 | 2017-01-25 | Алкон Рісерч, Лтд. | Офтальмологічна композиція з поліпшеним захистом від зневоднювання й утриманням |
| ES2908479T3 (es) | 2015-08-26 | 2022-04-29 | Achillion Pharmaceuticals Inc | Compuestos para el tratamiento de trastornos inmunitarios e inflamatorios |
| AR106018A1 (es) | 2015-08-26 | 2017-12-06 | Achillion Pharmaceuticals Inc | Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos |
| SG11201811491YA (en) | 2016-06-27 | 2019-01-30 | Achillion Pharmaceuticals Inc | Quinazoline and indole compounds to treat medical disorders |
| US11583496B2 (en) | 2016-10-12 | 2023-02-21 | PS Therapy Inc. | Drug vehicle compositions and methods of use thereof |
| EP4241759A1 (en) * | 2016-10-12 | 2023-09-13 | PS Therapy, Inc. | Artificial tear, contact lens and drug vehicle compositions and methods of use thereof |
| US11260035B2 (en) | 2016-10-12 | 2022-03-01 | Ps Therapies Ltd | Topical compositions and methods of use thereof |
| KR102632860B1 (ko) | 2017-03-01 | 2024-02-02 | 아칠리온 파르마세우티칼스 인코포레이티드 | 의학적 장애의 치료를 위한 아릴, 헤테로아릴, 및 헤테로사이클릭 약학적 화합물 |
| WO2020041301A1 (en) | 2018-08-20 | 2020-02-27 | Achillion Pharmaceuticals, Inc. | Pharmaceutical compounds for the treatment of complement factor d medical disorders |
| EP3846803A4 (en) | 2018-09-06 | 2022-08-10 | Achillion Pharmaceuticals, Inc. | Macrocyclic compounds for the treatment of medical disorders |
| WO2020081723A1 (en) | 2018-10-16 | 2020-04-23 | Georgia State University Research Foundation, Inc. | Carbon monoxide prodrugs for the treatment of medical disorders |
| TWI757773B (zh) * | 2019-06-28 | 2022-03-11 | 瑞士商愛爾康公司 | 眼用組成物 |
| EP4107166A4 (en) | 2020-02-20 | 2024-06-26 | Achillion Pharmaceuticals, Inc. | HETEROARYL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT FACTOR D-MEDIATED DISORDERS |
| JP7787164B2 (ja) | 2020-09-23 | 2025-12-16 | アキリオン ファーマシューティカルズ， インコーポレーテッド | 補体媒介性障害の治療のための医薬化合物 |
| US20250276007A1 (en) | 2024-03-04 | 2025-09-04 | Alcon Inc. | Carbamoylphenylboronic acid-containing acrylic monomers and uses thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8028A (en) * | 1851-04-08 | Hokse-poweb | ||
| US4136173A (en) * | 1977-01-31 | 1979-01-23 | American Home Products Corp. | Mixed xanthan gum and locust beam gum therapeutic compositions |
| DE3827561C1 (enExample) * | 1988-08-13 | 1989-12-28 | Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De | |
| US5505953A (en) * | 1992-05-06 | 1996-04-09 | Alcon Laboratories, Inc. | Use of borate-polyol complexes in ophthalmic compositions |
| DK1348427T3 (da) * | 1997-07-29 | 2008-06-30 | Alcon Lab Inc | Oftalmiske sammensætninger indeholdende galactomannanpolymerer og borater |
| GB9808461D0 (en) * | 1998-04-22 | 1998-06-17 | Innovative Tech Ltd | Solid borate-diol interaction products |
| US7084130B2 (en) * | 2001-12-11 | 2006-08-01 | Alcon, Inc. | Intraocular irrigating solution having improved flow characteristics |
| TWI336257B (en) * | 2003-06-13 | 2011-01-21 | Alcon Inc | Ophthalmic compositions containing a synergistic combination of three polymers |
| US20100021561A1 (en) * | 2006-09-21 | 2010-01-28 | Chowhan Masood A | Self-preserved aqueous pharmaceutical compositions |
| TWI434926B (zh) | 2006-12-11 | 2014-04-21 | Alcon Res Ltd | 眼用組成物中聚氧化乙烯-聚氧化丁烯（ｐｅｏ-ｐｂｏ）嵌段共聚物之使用 |
| TW200904485A (en) * | 2007-05-18 | 2009-02-01 | Alcon Res Ltd | Phospholipid compositions for contact lens care and preservation of pharmaceutical compositions |
| AR071834A1 (es) * | 2008-04-26 | 2010-07-21 | Alcon Res Ltd | Sistema polimerico de lagrimas artificiales |
| JP2012516936A (ja) | 2009-02-05 | 2012-07-26 | アルコン リサーチ， リミテッド | グアールを精製するためのプロセス |
-
2011
- 2011-05-04 MX MX2012012826A patent/MX2012012826A/es active IP Right Grant
- 2011-05-04 TW TW100115587A patent/TWI606841B/zh active
- 2011-05-04 CA CA2798069A patent/CA2798069C/en active Active
- 2011-05-04 EP EP11720357.0A patent/EP2566447B1/en active Active
- 2011-05-04 SG SG2012081386A patent/SG185422A1/en unknown
- 2011-05-04 AU AU2011248129A patent/AU2011248129B2/en active Active
- 2011-05-04 US US13/100,439 patent/US20110275593A1/en not_active Abandoned
- 2011-05-04 KR KR1020177037138A patent/KR20180001587A/ko not_active Ceased
- 2011-05-04 NZ NZ603345A patent/NZ603345A/en not_active IP Right Cessation
- 2011-05-04 KR KR1020127031590A patent/KR20130060228A/ko not_active Ceased
- 2011-05-04 CN CN2011800292803A patent/CN102939074A/zh active Pending
- 2011-05-04 BR BR112012028308-1A patent/BR112012028308B1/pt active IP Right Grant
- 2011-05-04 JP JP2013509217A patent/JP5794744B2/ja active Active
- 2011-05-04 CN CN201610986410.7A patent/CN106389325A/zh active Pending
- 2011-05-04 ES ES11720357T patent/ES2809304T3/es active Active
- 2011-05-04 WO PCT/US2011/035165 patent/WO2011140203A2/en not_active Ceased
- 2011-05-04 SG SG10201804305SA patent/SG10201804305SA/en unknown
- 2011-05-05 AR ARP110101556A patent/AR081015A1/es unknown
-
2012
- 2012-10-31 ZA ZA2012/08199A patent/ZA201208199B/en unknown
-
2013
- 2013-05-13 US US13/892,429 patent/US8846641B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| SG185422A1 (en) | 2012-12-28 |
| US20110275593A1 (en) | 2011-11-10 |
| TW201141524A (en) | 2011-12-01 |
| CA2798069A1 (en) | 2011-11-10 |
| KR20130060228A (ko) | 2013-06-07 |
| WO2011140203A2 (en) | 2011-11-10 |
| EP2566447B1 (en) | 2020-07-15 |
| CA2798069C (en) | 2016-07-05 |
| MX2012012826A (es) | 2013-01-28 |
| AU2011248129B2 (en) | 2014-10-09 |
| AR081015A1 (es) | 2012-05-30 |
| WO2011140203A3 (en) | 2012-04-19 |
| NZ603345A (en) | 2014-12-24 |
| US8846641B2 (en) | 2014-09-30 |
| ES2809304T3 (es) | 2021-03-03 |
| ZA201208199B (en) | 2014-01-29 |
| EP2566447A2 (en) | 2013-03-13 |
| BR112012028308A2 (pt) | 2016-11-01 |
| AU2011248129A1 (en) | 2012-11-29 |
| US20130244971A1 (en) | 2013-09-19 |
| TWI606841B (zh) | 2017-12-01 |
| JP5794744B2 (ja) | 2015-10-14 |
| KR20180001587A (ko) | 2018-01-04 |
| JP2013525493A (ja) | 2013-06-20 |
| CN106389325A (zh) | 2017-02-15 |
| BR112012028308B1 (pt) | 2021-09-28 |
| CN102939074A (zh) | 2013-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201804305SA (en) | Stabilized ophthalmic galactomannan formulations | |
| MX2013002422A (es) | Sales de lorcaserina con acidos opticamente activos. | |
| MX2014009757A (es) | Derivados de isoindolina, composiciones farmaceuticas que los contienen y su uso en terapia. | |
| AR112286A2 (es) | Sistema polimérico de lágrimas artificiales | |
| PH12013501136A1 (en) | Lysophosphatidic acid receptor antagonists and uses thereof | |
| IN2014MN02248A (enExample) | ||
| MX2013001677A (es) | Formulaciones estables de linaclotida. | |
| EA033171B1 (ru) | Полутвёрдая фармацевтическая композиция на водной основе, содержащая тапентадол | |
| TN2012000371A1 (en) | Pyrazole compounds as crth2 antagonists | |
| MX345404B (es) | Composiciones farmaceuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1h-bencimidazol- 2-il]-1h-quinolin-2-ona. | |
| TN2012000261A1 (en) | Aerosol formulation for copd | |
| PH12015501377A1 (en) | Solid unit with high fexofenadine content and process for the preparation thereof | |
| MX2012006265A (es) | Formulaciones disacaridas hipersulfatadas. | |
| MX2014004210A (es) | Derivados de 2-oxo-piperidinilo. | |
| WO2011076840A3 (en) | Aerosol formulation for copd | |
| MX2015007794A (es) | Suministro transmucosal de acetato de glatiramer mediante parches orales. | |
| TW200718698A (en) | Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof | |
| BR112012020828A2 (pt) | preparado farmacêutico que contém miramistina | |
| WO2013083226A8 (de) | Porenarmes, wasserfreies natriumcarbonat | |
| WO2009121946A3 (en) | Process for the preparation of optically enriched clopidogrel | |
| TR201105424A2 (tr) | Çinko etken maddeli bir farmasötik formülasyon. | |
| WO2012108794A3 (ru) | Производные 1,2,4-триазол-з-илтиогликолевой кислоты для применения в терапии | |
| IN2013DE00880A (enExample) | ||
| CO7141425A2 (es) | Composiciones oftálmicas con retención y protección de desecación mejoradas | |
| UA78605U (en) | Pharmaceutical composition |